The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Pharmacogenomics: bench to bedside
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., de Boer, A., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,447
Weinshilboum, R. M., & Sladek, S. L. (1980) · PubMed · Cited by 1,195
Self-citationPOLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Weinshilboum, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,031
Self-citationZerhouni, E. (2003) · Science · doi:10.1126/science.1091867 · Cited by 918
Genetic Control of Isoniazid Metabolism in Man
Evans, D. A. P., Manley, K. A., & McKusick, V. A. (1960) · BMJ · doi:10.1136/bmj.2.5197.485 · Cited by 784
Medical and Ethical Consequences of the Human Genome Project
Collins, F. S. (1991) · The Journal of Clinical Ethics · doi:10.1086/jce199102411 · Cited by 666
The clinical pharmacology of 6-mercaptopurine
Lennard, L. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02220605 · Cited by 647
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
Eichelbaum, M., Spannbrucker, N., Steincke, B., & Dengler, H. J. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562059 · Cited by 632
Lennard, L., Van Loon, J. A., & Weinshilboum, R. M. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.119 · Cited by 593
Self-citationGenetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome
Monaghan, G., Ryan, M., Hume, R., Burchell, B., & Seddon, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91273-8 · Cited by 585
Medical and Societal Consequences of the Human Genome Project
Collins, F. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410106 · Cited by 578
Drazen, J. M., Yandava, C. N., Dubé, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 560
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 549
Self-citationBertilsson, L., Lou, Y.-Q., Du, Y.-L., Liu, Y., Kuang, T.-Y., Liao, X.-M., Wang, K.-Y., Reviriego, J., Iselius, L., & Sjöqvist, F. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.38 · Cited by 399
Aklillu, E., Persson, I., Bertilsson, L., Johansson, I., Rodrigues, F., & Ingelman-Sundberg, M. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20152-5 · Cited by 392
Woosley, R. L., Drayer, D. E., Reidenberg, M. M., Nies, A. S., Carr, K., & Oates, J. A. (1978) · New England Journal of Medicine · doi:10.1056/nejm197805252982101 · Cited by 389
Discombe, G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91898-4 · Cited by 376
Collie-Duguid, E. S. R., Pritchard, Powrie, Sludden, J., Collier, Li, T., & McLeod, H. L. (1999) · Pharmacogenetics · doi:10.1097/00008571-199902000-00006 · Cited by 368
The pharmacological basis of therapeutics
Gangarosa, L. P., & Jeske, A. H. (1976) · The Journal of Prosthetic Dentistry · doi:10.1016/0022-3913(76)90337-1 · Cited by 366
Ethical, Legal, and Social Implications of Genomic Medicine
Clayton, E. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012577 · Cited by 330
Goldstein, D. B., Tate, S. K., & Sisodiya, S. M. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1229 · Cited by 312
SZUMLANSKI, C., OTTERNESS, D., HER, C., LEE, D., BRANDRIFF, B., KELSELL, D., SPURR, N., LENNARD, L., WIEBEN, E., & WEINSHILBOUM, R. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.17 · Cited by 305
Self-citationInherited disorders of bilirubin metabolism
Bosma, P. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00359-8 · Cited by 279
Guttmacher, A. E., & Collins, F. S. (2003) · New England Journal of Medicine · doi:10.1056/nejme038132 · Cited by 262
Tai, H.-L., Krynetski, E. Y., Schuetz, E. G., Yanishevski, Y., & Evans, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6444 · Cited by 259
Perry, H. M., Tan, E. M., Carmody, S. E., et al. (1970) · PubMed · Cited by 257
Pharmacogenetics. Heredity and the Response to Drugs.
(1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-4-757 · Cited by 242
Schütz, E., Gummert, J., Mohr, F., & Oellerich, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)93028-y · Cited by 222
Genetic Control of Drug Levels in Man: Antipyrine
Vesell, E. S., & Page, J. G. (1968) · Science · doi:10.1126/science.161.3836.72 · Cited by 220
The pharmacogenetics of codeine hypoalgesia
Sindrup, S. H., & Br??sen, K. (1995) · Pharmacogenetics · doi:10.1097/00008571-199512000-00001 · Cited by 201
Polymorphic acetylation of procainamide in man
Reidenberg, M. M., Drayer, D. E., Levy, M., & Warner, H. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975176722 · Cited by 180
Metabolism of Thiopyrimidines and Thiopurines
Remy, C. N. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81262-5 · Cited by 172
Genome-based pharmacogenetics and the pharmaceutical industry
Roses, A. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd840 · Cited by 168
Kroemer, H. K., & Eichelbaum, M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00223-s · Cited by 160
Gonzalez, F. J., Vilbois, F., Hardwick, J. P., et al. (1988) · Genomics · doi:10.1016/0888-7543(88)90100-0 · Cited by 157
Genetic control of dicumarol levels in man
Vesell, E. S., & Page, J. G. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105949 · Cited by 153
Pharmacogenomics and ???Individualized Drug Therapy???
Nebert, D. W., Jorge-Nebert, L. F., & Vesell, E. S. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303060-00002 · Cited by 137
The relative power of SNPs and haplotype as genetic markers for association tests
Bader, J. S. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.1.11 · Cited by 136
Human kidney thiopurine methyltransferase purification and biochemical properties
Woodson, L. C., & Weinshilboum, R. M. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90582-8 · Cited by 133
Self-citationWang, L., Sullivan, W., Toft, D. O., & Weinshilboum, R. M. (2003) · Pharmacogenetics · doi:10.1097/00008571-200309000-00004 · Cited by 93
Self-citationARYLAMINEN-ACETYLTRANSFERASE ACTIVITY IN MAN
Cascorbi, I., Brockmöller, J., Mrozikiewicz, P. M., Müller, A., & Roots, I. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101932 · Cited by 86
Surviving the Blockbuster Syndrome
Service, R. F. (2004) · Science · doi:10.1126/science.303.5665.1796 · Cited by 86
Weinshilboum, R. M. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.184 · Cited by 81
Self-citationGenetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics
Evans, P., & Dávid, A. (1994) · Cited by 67
From the Molecule to the Clinic — Inhibiting HER2 to Treat Breast Cancer
Eisenhauer, E. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441110 · Cited by 64
Fenech, A. G., & Hall, I. P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01509.x · Cited by 63
Pharmacogenetics: inherited variation in amino acid sequence and altered protein quantity*1
Weinshilboum, R. M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.002 · Cited by 45
Self-citationGuttmacher, A. F. (2004) · Johns Hopkins University Press eBooks · doi:10.56021/9780801879791 · Cited by 13
Pharmacogenetics of drug metabolism. International encyclopedia of pharmacology and therapeutics
Kietzmann, M. (1993) · Toxicon · doi:10.1016/0041-0101(93)90266-l · Cited by 8
Cited by
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Personalized Medicine: Progress and Promise
Chan, I. S., & Ginsburg, G. S. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101446 · Cited by 399
Elucidating mechanisms of drug-induced toxicity
Liebler, D. C., & Guengerich, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1720 · Cited by 323
van der Wouden, C., Cambon‐Thomsen, A., Cecchin, E., Cheung, K., Dávila‐Fajardo, C., Deneer, V., Dolžan, V, Ingelman‐Sundberg, M., Jönsson, S., Karlsson, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.602 · Cited by 306
Metadata
- Authors
- Weinshilboum, R., & Wang, L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-09
- Volume
- 3
- Issue
- 9
- Pages
- 739-748
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2084815355
- Cited by
- 320
- References
- 58
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.